Growth % Var 16-17 Var 17-18 Var 18-19 Var 19-20

Revenue 8.6% -5.3% 18.0% -27.1%

Gross profit 13.0% -11.4% 15.8% -24.3%
EBITDA 17.0% -35.9% 13.6% -3.1%
EBIT 19.9% -43.2% 16.0% 9.5%
EBT 19.6% -43.0% 15.6% 9.9%
net income 40.9% -54.1% 106.6% -10.5%

Profitability Ratio 2016 2017 2018 2019 2020 Industrial AVG

ROE 6.1% 7.9% 3.5% 6.9% 5.8% 12.65%
ROA 5.2% 7.0% 3.1% 6.0% 5.3%
ROCE 7.2% 8.0% 4.4% 4.9% 5.1%
Gross margin ratio 54% 56% 52% 51% 53%
operating profit margin 18% 20% 12% 12% 18%
Net profit margin 15% 19% 9% 16% 20%

Leverage Ratio 2016 2017 2018 2019 2020

Debt-to-Equity Ratio 6.0% 2.0% 1.0% 0.0% 0.0%
Equity Ratio 84.5% 87.6% 87.2% 86.3% 90.7%
Debt Ratio 5.1% 1.8% 0.9% 0.0% 0.0%

Liquidity ratio 2016 2017 2018 2019 2020

current ratio 2.75 3.37 2.47 2.46 2.86
Quick Ratio 1.28 2.04 1.93 2.02 2.35
Cash ratio 75% 54% 24% 36% 52%
 Mar'16 Mar'17 Mar'18 Mar'19 Mar'20
P&L of BIOCON (in Rs cr) 12Months 12Months 12Months 12Months 12Months
INCOME:
Sales Turnover 2335.4 2618.4 2425.5 2884.7 1988.4
Excise Duty 33.6 30.5 6.3 0 0
NET SALES 2301.8 2587.9 2419.2 2884.7 1988.4
Other Income 173.1 98.8 124.7 117.5 201.7
TOTAL INCOME 2474.9 2686.7 2543.9 3002.2 2190.1
Manufacturing Expenses 155.1 145.6 161 201.8 193.3
Material Consumed 987.5 1035.2 1049.4 1256.8 827.7
COGS 1142.6 1180.8 1210.4 1458.6 1021
Gross profit 1332.3 1505.9 1333.5 1543.6 1169.1
Personal Expenses 321.9 365 408.6 510.3 344.8
Selling Expenses 42.3 47.4 47.7 44.8 0
Administrative Expenses 378 402.9 434.3 485.4 336.6
Expenses Capitalised 0 0 0 0 0
Provisions Made 0 0 0 0 0
Operating exp 742.2 815.3 890.6 1040.5 681.4
TOTAL EXPENDITURE 1884.8 1996.1 2101 2499.1 1702.4
EBITDA 590.1 690.6 442.9 503.1 487.7
Depreciation 139.7 150.6 136.1 147.1 98
Other Write-offs 0 0 0 0 0
EBIT 450.4 540 306.8 356 389.7
Interest 1.9 3.8 1 2.6 1.2
EBT 448.5 536.2 305.8 353.4 388.5
Taxes 190.8 16.9 67.3 59.4 111.9
Profit and Loss for the Year 257.7 519.3 238.5 294 276.6
Non Recurring Items 110.9 0 0 198.7 164.3
Other Non Cash Adjustments 0 0 0 0 0
Other Adjustments 0 0 0 0 0
REPORTED PAT 368.6 519.3 238.5 492.7 440.9
Balance sheet
2016-2020

BALANCE SHEET OF BIOCON (in Rs. Cr.) ### ### ### ### B1Mar/20
12 mths 12 mths 12 mths 12 mths 12 mths
Equity Share Capital 100 100 300 300 600
TOTAL SHARE CAPITAL 100 100 300 300 600
Reserves and Surplus 5,895.70 6,440.20 6,437.70 6,814.50 6,936.40
TOTAL RESERVES AND SURPLUS 5,896.60 6,441.10 6,438.60 6,815.40 6,937.30
TOTAL SHAREHOLDERS FUNDS 5,996.60 6,541.10 6,738.60 7,115.40 7,537.30
NON-CURRENT LIABILITIES
Long Term Borrowings 136.5 132.4 67.2 1.4 0.7
Deferred Tax Liabilities [Net] 0.9 0 0 0 0
Other Long Term Liabilities 92 76.9 72.3 105.5 23.4
Long Term Provisions 9.5 13.3 17.2 24.8 21.4
TOTAL NON-CURRENT LIABILITIES 238.9 222.6 156.7 131.7 45.5
CURRENT LIABILITIES
Short Term Borrowings 225.5 0 0 0 0
Trade Payables 394.4 450.5 579.7 643.9 521.2
Other Current Liabilities 214.2 222.7 220.3 294.6 182.4
Short Term Provisions 28.5 32 31.6 54.8 24.4
TOTAL CURRENT LIABILITIES 862.6 705.2 831.6 993.3 728
TOTAL CAPITAL AND LIABILITIES 7,098.10 7,468.90 7,726.90 8,240.40 8,310.80
ASSETS
NON-CURRENT ASSETS
Tangible Assets 859.6 864.9 834.1 1,029.10 659
Intangible Assets 34.2 29.2 24.7 30.1 61.7
Capital Work-In-Progress 172.3 240.8 318.5 254.5 151.9
Other Assets 43.9 43.9 43.8 41.9 72.5
FIXED ASSETS 1,110.00 1,178.80 1,221.10 1,355.60 945.1
Non-Current Investments 3,210.60 3,363.50 3,745.20 3,902.80 4,814.00
Deferred Tax Assets [Net] 0 105.4 102.2 201.9 179.5
Long Term Loans And Advances 158.4 192.3 281.7 106.6 156.7
Other Non-Current Assets 248 250.4 319 227.1 131.8
TOTAL NON-CURRENT ASSETS 4,727.00 5,090.40 5,669.20 5,794.00 6,227.10
CURRENT ASSETS
Current Investments 598.3 524.7 453.8 113.4 138.8
Inventories 504.6 539.6 561.7 801.9 534.7
Trade Receivables 503.8 798.2 739.9 901.8 573.2
Cash And Cash Equivalents 643 382.9 196.9 356 375.3
Short Term Loans And Advances 0 0 0 91.8 100.6
OtherCurrentAssets 121.4 133.1 105.4 181.5 361.1
TOTAL CURRENT ASSETS 2,371.10 2,378.50 2,057.70 2,446.40 2,083.70
TOTAL ASSETS 7,098.10 7,468.90 7,726.90 8,240.40 8,310.80